Device Cardiology/Vascular Diseases

Cs300 Intra-Aortic Balloon Pump, English, 110v

Payments companies reported to CMS as associated with Cs300 Intra-Aortic Balloon Pump, English, 110v. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1,332associated payments (2023-2025)
46clinicians with associated payments
1company reporting

By year

2023 $345
2024 $782
2025 $205

Payments reported as associated with Cs300 Intra-Aortic Balloon Pump, English, 110v, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Interventional Cardiology $388
Internal Medicine $368
Cardiovascular Disease $184
Surgical $56.17
Anesthesiology $53.02
Hospitalist $39.87

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Cs300 Intra-Aortic Balloon Pump, English, 110v

These are the largest totals companies reported as associated with Cs300 Intra-Aortic Balloon Pump, English, 110v. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Radhika Deshpande Springfield, IL Internal Medicine $69.12
Sudhir Mungee Peoria, IL Interventional Cardiology $69.11
Marco Barzallo Peoria, IL Cardiovascular Disease $61.42
Sriviji Senthil Kumaran Peoria, IL Internal Medicine $47.57
Dennis Kumi Chicago, IL Internal Medicine $47.13
Shreyas Singireddy Athens, GA $47.13
Sami Shoura Chicago, IL Internal Medicine $47.13
Ashvarya Mangla Chicago, IL Interventional Cardiology $43.53
Rimmy Farrakhan Clinton, MD Interventional Cardiology $39.87
Kailash Pant Deland, FL Interventional Cardiology $39.87

Prescribed Cs300 Intra-Aortic Balloon Pump, English, 110v?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.